Medicine & Life Sciences
Adenomyoma
100%
Erythema Multiforme
86%
Janus Kinase Inhibitors
84%
Transgender Persons
80%
Warts
76%
Dysmenorrhea
75%
antineoplaston A10
74%
Sexual Health
71%
Progestins
66%
Leiomyoma
66%
Cervix Uteri
60%
Tumor Biomarkers
59%
Progesterone
56%
Health Services
53%
Squamous Cell Carcinoma
50%
Hypersensitivity
49%
Inpatients
48%
Gender Dysphoria
47%
Pediatrics
47%
Pelvic Pain
47%
HIV
41%
Imiquimod
41%
Stomatitis
37%
Luteal Phase
35%
Population
30%
Standard of Care
29%
Adenomyosis
27%
Ointments
26%
Child
26%
Quality of Health Care
26%
Therapeutics
24%
Primary Health Care
23%
Patient Care
23%
Hormones
21%
Pain
20%
Uterine Cervical Neoplasms
18%
alpha-Fetoproteins
16%
Chorionic Gonadotropin
16%
Neoplasms
15%
Growth
15%
L-Lactate Dehydrogenase
15%
Laparotomy
13%
Defense Mechanisms
13%
Antigens
13%
inhibin A
11%
Recurrence
11%
Papillomavirus Infections
11%
inhibin B
10%
Immunocompromised Host
10%
Podophyllin
10%
Adolescent Medicine
10%
Sexually Transmitted Diseases
9%
Hospitalists
9%
Sexual Behavior
9%
Hospital Medicine
9%
Demography
8%
Pediatric Hospitals
7%
Papillomavirus Vaccines
7%
Child Health
7%
Hispanic Americans
7%
Cimetidine
7%
Fertility
7%
Gynecology
6%
Erythema
6%
Candida
6%
Biopsy
6%
Histology
5%
Surgeons
5%